Background: The World Health Organization recommends that antiretroviral therapy (ART)
programs in resource-limited settings develop third-line ART policies. South Africa …

Background Despite remarkable progress, HIV's influence on global health remains firm,
demanding continued attention. Understanding the effectiveness of third-line antiretroviral …

Simple Summary DNA immunization with drug-resistant HIV-1 protease (DR PR) is
proposed as immunotherapy to prevent the evolution of HIV-1 towards drug resistance and …

Background While efficacy data exist, there are limited data on the outcomes of patients on
third-line antiretroviral therapy (ART) in sub-Saharan Africa in actual practice. Being able to …

Background In resource-limited settings, multi-experienced HIV infected patients are often
prescribed raltegravir for salvage therapy. Patients failing raltegravir-containing regimens …

Background Antiretroviral therapy (ART) has been proven to be highly effective in reducing
the impact of human immunodeficiency virus (HIV) infection. However, as more people …

Introduction Failure on second-line antiretroviral therapy (ART) with protease inhibitor (PI)
mutations (VF-M) is on the rise. However, there is a paucity of information on the factors …

Background: Efficacy and safety data of third-line antiretroviral (ARV) regimens in
adolescents are limited. Methodology: This study enrolled HIV-infected Thais who were …

Introduction Latinos living with HIV in the Americas share a common ethnic and cultural
heritage. In North America, Latinos have a relatively high rate of new HIV infections but …

Background Efavirenz (EFV) and boosted protease inhibitors (bPIs) are still the preferred
options for firstline antiretroviral regimens (firstline ART) in Latin America and have …